Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Not applicableLooking for participantsNCT04582903
What this trial is testing

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

Who this might be right for
COVID-19 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Testing effectiveness (Phase 2)UnknownNCT04299152
What this trial is testing

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome (SARS) Pneumonia
Throne Biotechnologies Inc. 20
Not applicableStudy completedNCT04490200
What this trial is testing

Effectiveness of a Novel Respirator With Chitosan Nanoparticles

Who this might be right for
Covid19SARS-CoV InfectionWorker-Patient Transmission, Healthcare
University of Brasilia 300
Testing effectiveness (Phase 2)Study completedNCT04710199
What this trial is testing

Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Virus Diseases
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 44
Large-scale testing (Phase 3)Study completedNCT04510493
What this trial is testing

Canakinumab in Patients With COVID-19 and Type 2 Diabetes

Who this might be right for
Coronavirus InfectionDiabetes Mellitus, Type 2
University Hospital, Basel, Switzerland 116
Not applicableStudy completedNCT04583319
What this trial is testing

Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection

Who this might be right for
SARS-CoV
Firalis SA 300
Not applicableStudy completedNCT04885452
What this trial is testing

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Who this might be right for
SARS-CoV InfectionCovid19
ANRS, Emerging Infectious Diseases 756
Large-scale testing (Phase 3)UnknownNCT04351152
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
Humanigen, Inc. 520
Not applicableUnknownNCT04375176
What this trial is testing

Monocytes and NK Cells Activity in Covid-19 Patients

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome Coronavirus 2Immunomodulation
Università degli Studi dell'Insubria 150
Testing effectiveness (Phase 2)Ended earlyNCT04409873
What this trial is testing

Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)

Who this might be right for
COVID-19SARS-CoV 2Severe Acute Respiratory Syndrome Coronavirus 2+3 more
University of California, San Francisco 54
Testing effectiveness (Phase 2)UnknownNCT04395456
What this trial is testing

The C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)

Who this might be right for
Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)
Amyndas Pharmaceuticals S.A. 144
Early research (Phase 1)UnknownNCT05212532
What this trial is testing

A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Respiratory Distress Syndrome
EOM Pharmaceuticals 40
Not applicableStudy completedNCT05092698
What this trial is testing

The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19

Who this might be right for
SARS-CoV2 Infection
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 110
Not applicableUnknownNCT04893668
What this trial is testing

Depression and Anxiety in Long Term Coronavirus Disease COVID-19

Who this might be right for
Covid19DepressionAnxiety
Hasanuddin University 165
Testing effectiveness (Phase 2)UnknownNCT04594668
What this trial is testing

Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency

Who this might be right for
ARDS, HumanCOVID
University of Aarhus 46
Testing effectiveness (Phase 2)WithdrawnNCT04626089
What this trial is testing

Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Metabolic SyndromeType 2 Diabetes
Laboratorios Silanes S.A. de C.V.
Large-scale testing (Phase 3)UnknownNCT04984408
What this trial is testing

Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

Who this might be right for
COVID-19 Disease
International Vaccine Institute 8,825
Large-scale testing (Phase 3)WithdrawnNCT04452474
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

Who this might be right for
COVID-19
R-Pharm
Large-scale testing (Phase 3)Ended earlyNCT04405271
What this trial is testing

TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)

Who this might be right for
Healthcare WorkersCOVID-19SARS-CoV 2
Hospital Italiano de Buenos Aires 1,378
Next Page